Unified Neural Architecture for Drug, Disease and Clinical Entity Recognition
Most existing methods for biomedical entity recognition task rely on explicit feature engineering where many features either are specific to a particular task or depends on output of other existing NLP tools. Neural architectures have been shown across various domains that efforts for explicit feature design can be reduced. In this work we propose an unified framework using bi-directional long short term memory network (BLSTM) for named entity recognition (NER) tasks in biomedical and clinical domains. Three important characteristics of the framework are as follows - (1) model learns contextual as well as morphological features using two different BLSTM in hierarchy, (2) model uses first order linear conditional random field (CRF) in its output layer in cascade of BLSTM to infer label or tag sequence, (3) model does not use any domain specific features or dictionary, i.e., in another words, same set of features are used in the three NER tasks, namely, disease name recognition (Disease NER), drug name recognition (Drug NER) and clinical entity recognition (Clinical NER). We compare performance of the proposed model with existing state-of-the-art models on the standard benchmark datasets of the three tasks. We show empirically that the proposed framework outperforms all existing models. Further our analysis of CRF layer and word-embedding obtained using character based embedding show their importance.
Code (0)
등록된 구현이 없습니다.
Tasks
Feature Engineeringnamed-entity-recognitionNamed Entity RecognitionNamed Entity Recognition (NER)NERTAGMethods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Drug and Disease Interpretation Learning with Biomedical Entity Representation Transformer
Concept normalization in free-form texts is a crucial step in every text-mining pipeline. Neural architectures based on Bidirectional Encoder Representations from Transformers (BERT) have achieved state-of-the-art result…
Drug DiscoveryMetric LearningTransfer LearningTripletDeceptive Grounding: Entity Attribution Failure in Clinical Retrieval-Augmented Generation
Retrieval-augmented generation evaluation checks whether model claims are factually grounded in retrieved documents. It does not check whether retrieved evidence is attributed to the correct entity. A clinical RAG respon…
CCS Explorer: Relevance Prediction, Extractive Summarization, and Named Entity Recognition from Clinical Cohort Studies
Clinical Cohort Studies (CCS), such as randomized clinical trials, are a great source of documented clinical research. Ideally, a clinical expert inspects these articles for exploratory analysis ranging from drug discove…
ArticlesDrug DiscoveryExtractive Summarizationnamed-entity-recognition+3A Biomedical Entity Extraction Pipeline for Oncology Health Records in Portuguese
Textual health records of cancer patients are usually protracted and highly unstructured, making it very time-consuming for health professionals to get a complete overview of the patient's therapeutic course. As such lim…
Entity LinkingGNTeam at 2018 n2c2: Feature-augmented BiLSTM-CRF for drug-related entity recognition in hospital discharge summaries
Monitoring the administration of drugs and adverse drug reactions are key parts of pharmacovigilance. In this paper, we explore the extraction of drug mentions and drug-related information (reason for taking a drug, rout…
Entity Extraction using GANnamed-entity-recognitionNamed Entity RecognitionNamed Entity Recognition (NER)+2